A small Australian-led study appears to hint that treating patients diagnosed with ongoing intracerebral haemorrhage with the common anti-fibrinolytic agent tranexamic acid may limit the size of the haemorrhages. In the Phase II Spot Sign and Tranexamic Acid on Preventing ICH Growth – Australasia Trial (STOP-AUST), Dr Nawaf Yassi, consultant neurologist at the Royal Melbourne ...
Old medicine may have new use in intracerebral haemorrhage: SPOT-AUST study
By Ed Susman
27 Feb 2020